Calpain translocation and activation as pharmacological targets during myocardial ischemia/reperfusion
Author
dc.contributor.author
Hernando, Víctor
Author
dc.contributor.author
Inserte, Javier
Author
dc.contributor.author
Sartório, Carmem Luíza
Author
dc.contributor.author
Parra, Víctor M.
Author
dc.contributor.author
Poncelas-Nozal, Marcos
Author
dc.contributor.author
Garcia-Dorado, David
Admission date
dc.date.accessioned
2019-03-11T13:00:04Z
Available date
dc.date.available
2019-03-11T13:00:04Z
Publication date
dc.date.issued
2010
Cita de ítem
dc.identifier.citation
Journal of Molecular and Cellular Cardiology, Volumen 49, Issue 2, 2018, Pages 271-279
Identifier
dc.identifier.issn
00222828
Identifier
dc.identifier.other
10.1016/j.yjmcc.2010.02.024
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165016
Abstract
dc.description.abstract
Calpains contribute to reperfusion-induced myocardial cell death. However, it remains controversial whether its activation occurs during ischemia or reperfusion. We investigated the regulation and time-course of calpain activation secondary to transient ischemia and the efficacy of its inhibition at reperfusion as a therapeutic strategy to limit infarct size. In isolated rat hearts (Sprague-Dawley), ischemia induced a time-dependent translocation of m-calpain to the membrane that was not associated with calpain activation as assessed by proteolysis of its substrate α-fodrin. Translocation of calpain was dependent on Ca2+ entry through reverse mode Na+/Ca2+-exchange and was independent of acidosis. Calpain activation occurred during reperfusion, but only after intracellular pH (pHi) normalization, and was not prevented by inhibiting its translocation during ischemia with methyl-β-cyclodextrin. The intravenous infusion of MDL-28170 in an in vivo rat model with transient coronary occlusio